Phase I trial of ACE-393 (Campylobacter jejuni vaccine)
Latest Information Update: 21 Mar 2014
At a glance
- Drugs ACE 393 (Primary)
- Indications Campylobacter infections; Traveller's diarrhoea
- Focus Adverse reactions; Registrational
- Sponsors ACE BioSciences
- 06 Sep 2006 New trial record.